<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR17">
 <label>17.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Al-Shafa</surname>
    <given-names>F</given-names>
   </name>
   <name>
    <surname>Arifin</surname>
    <given-names>AJ</given-names>
   </name>
   <name>
    <surname>Rodrigues</surname>
    <given-names>GB</given-names>
   </name>
   <name>
    <surname>Palma</surname>
    <given-names>DA</given-names>
   </name>
   <name>
    <surname>Louie</surname>
    <given-names>AV</given-names>
   </name>
  </person-group>
  <article-title>A review of Ongoing trials of stereotactic ablative radiotherapy for Oligometastatic cancers: where will the evidence Lead?</article-title>
  <source>Front Oncol</source>
  <year>2019</year>
  <volume>9</volume>
  <fpage>543</fpage>
  <pub-id pub-id-type="doi">10.3389/fonc.2019.00543</pub-id>
  <?supplied-pmid 31293976?>
  <pub-id pub-id-type="pmid">31293976</pub-id>
 </element-citation>
</ref>
